Holding(s) in Company

RNS Number : 1832C
Cizzle Biotechnology Holdings PLC
18 February 2022
 

 

 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in MicrosoftWordformatifpossible) i

 

1a. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached i i :

 

CizzleBiotechnologyHoldingsPlc

1b.Pleaseindicateiftheissueris anon-UKissuer (pleasemarkwithan"X"ifappropriate)

Non-UKissuer

 

2.Reasonforthe notification (please marktheappropriateboxorboxes withan"X")

Anacquisition ordisposalofvotingrights

X

Anacquisition ordisposaloffinancialinstruments

 

Aneventchangingthebreakdownof votingrights

 

Other(pleasespecify) iii :

 

3.Detailsofpersonsubjecttothe notificationobligation iv

Name

ConduitPharmaceuticalsLimited

Cityandcountryofregisteredoffice(ifapplicable)

 

4.Fullname ofshareholder(s) (ifdifferentfrom 3.) v

Name

Cityandcountryofregisteredoffice(ifapplicable)

 

5. Date on which the threshold was crossed orreached vi :

16/02/2022

6.Dateonwhichissuernotified (DD/MM/YYYY):

18/02/2022

7.Totalpositionsofperson(s)subjecttothenotificationobligation

 

% of voting rightsattachedtoshares(totalof8.A)

%ofvotingrightsthrough financialinstruments

(totalof8.B1+ 8.B2)

 

Totalofbothin%(8.A+8.B)

Total number ofvotingrightsheld

inissuer(8.A+8.B) vii

Resulting situationonthe dateonwhichthreshold wascrossedorreached

 

8.98%

 

0.00%

 

8.98%

 

25,000,000

Positionofpreviousnotification(ifapplicable)

 

0.00%

 

0.00%

 

0.00%

 

              

8. Notified details of the resulting situation on the date on which the threshold was crossed orreached viii

A:Votingrightsattachedtoshares

Class/type ofshares

ISINcode(ifpossible)

Numberofvotingrights ix

%ofvotingrights

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

OrdinaryShares

 

GB00BNG2VN02

 

25,000,000

 

0

 

8.98%

 

0.00%

 

 

 

 

 

 

 

 

 

 

SUBTOTAL8.A

25,000,000

8.98%

 

B1:FinancialInstrumentsaccordingtoDTR5.3.1R(1) (a)

 

Typeoffinancialinstrument

 

Expiration date x

 

Exercise/ConversionPeriod xi

Numberofvotingrightsthatmaybeacquiredif

the instrument isexercised/converted.

 

%ofvotingrights

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL8.B1

 

 

 

B2:FinancialInstrumentswithsimilareconomiceffectaccordingtoDTR5.3.1R(1)(b)

Typeoffinancialinstrument

Expiration date x

Exercise/ConversionPeriod xi

Physical orcashSettlement xii

Number ofvotingrights

 

%ofvotingrights

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL8.B.2

 

 

                   

   

9. Information in relation to the person subject to the notification obligation (please mark theapplicable boxwithan"X")

Personsubjecttothenotificationobligation isnotcontrolledbyanynaturalperson orlegalentityand doesnotcontrolanyotherundertaking(s)holdingdirectlyorindirectlyaninterestinthe(underlying)issuerxiii

 

Full chain ofcontrolled undertakings throughwhichthevotingrightsand/orthe

financialinstrumentsareeffectivelyheldstartingwiththeultimatecontrolling naturalperson orlegalentity(pleaseaddadditional rowsasnecessary) xiv

 

 

 

Name xv

%of votingrights if itequals or is higherthan the notifiablethreshold

% of voting rightsthrough financialinstruments if it equalsorishigherthan the

notifiablethreshold

Total of both if itequals or is higherthan the notifiablethreshold

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In caseofproxyvoting,please identify:

Name oftheproxyholder

 

The numberand %ofvotingrightsheld

 

Thedateuntilwhich the votingrightswillbeheld

 

 

11.Additionalinformation xvi

 

         

 

Placeofcompletion

CaymanIslands

Dateofcompletion

17/02/2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUWVVRUUUUAAR
UK 100

Latest directors dealings